169 related articles for article (PubMed ID: 34885096)
1. Comparison of Clinical Outcomes of Radical Prostatectomy versus IMRT with Long-Term Hormone Therapy for Relatively Young Patients with High- to Very High-Risk Localized Prostate Cancer.
Shih HJ; Chang SC; Hsu CH; Lin YC; Hung CH; Wu SY
Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885096
[TBL] [Abstract][Full Text] [Related]
2. The Latest Data Specifically Focused on Long-Term Oncologic Prognostication for Very Old Adults with Acute Vulnerable Localized Prostate Cancer: A Nationwide Cohort Study.
Wu SY; Effendi FF; Canales RE; Huang CC
J Clin Med; 2022 Jun; 11(12):. PubMed ID: 35743522
[TBL] [Abstract][Full Text] [Related]
3. Oncologic Outcomes of Radical Prostatectomy and High-Dose Intensity-Modulated Radiotherapy with Androgen-Deprivation Therapy for Relatively Young Patients with Unfavorable Intermediate-Risk Prostate Adenocarcinoma.
Wu SY; Chang SC; Chen CI; Huang CC
Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33806181
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Medical Resource Consumption of Radical Prostatectomy vs. Intensity-Modulated Radiotherapy for Old Patients With Prostate Cancer: A Nationwide Population-Based Cohort Study.
Wu SY; Effendi FF; Peng JY; Huang CC
Front Med (Lausanne); 2022; 9():843709. PubMed ID: 35592854
[TBL] [Abstract][Full Text] [Related]
5. Acute, Subchronic, and Chronic Complications of Radical Prostatectomy Versus Radiotherapy With Hormone Therapy in Older Adults With High-Risk Prostate Adenocarcinoma.
Wu SY; Huy LD; Liao CJ; Huang CC
Front Oncol; 2022; 12():875036. PubMed ID: 35586485
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of treatment for localized prostate cancer in a single institution: comparison of radical prostatectomy and radiation therapy by propensity score matching analysis.
Hayashi N; Osaka K; Muraoka K; Hasumi H; Makiyama K; Kondo K; Nakaigawa N; Yao M; Mukai Y; Sugiura M; Takano S; Ito E; Kaizu H; Koike I; Hata M; Taguri M; Miyoshi Y; Izumi K; Kawahara T; Uemura H
World J Urol; 2020 Oct; 38(10):2477-2484. PubMed ID: 31875247
[TBL] [Abstract][Full Text] [Related]
7. Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical Prostatectomy.
Jackson WC; Schipper MJ; Johnson SB; Foster C; Li D; Sandler HM; Palapattu GS; Hamstra DA; Feng FY
Eur Urol; 2016 Jan; 69(1):50-7. PubMed ID: 26004800
[TBL] [Abstract][Full Text] [Related]
8. Radical prostatectomy or radiotherapy for high- and very high-risk prostate cancer: a multidisciplinary prostate cancer clinic experience of patients eligible for either treatment.
Reichard CA; Hoffman KE; Tang C; Williams SB; Allen PK; Achim MF; Kuban DA; Chapin BF
BJU Int; 2019 Nov; 124(5):811-819. PubMed ID: 31009137
[TBL] [Abstract][Full Text] [Related]
9. Use of Concomitant Androgen Deprivation Therapy in Patients Treated with Early Salvage Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: Long-term Results from a Large, Multi-institutional Series.
Gandaglia G; Fossati N; Karnes RJ; Boorjian SA; Colicchia M; Bossi A; Seisen T; Cozzarini C; Di Muzio N; Noris Chiorda B; Zaffuto E; Wiegel T; Shariat SF; Goldner G; Joniau S; Battaglia A; Haustermans K; De Meerleer G; Fonteyne V; Ost P; Van Poppel H; Montorsi F; Briganti A
Eur Urol; 2018 Apr; 73(4):512-518. PubMed ID: 29229176
[TBL] [Abstract][Full Text] [Related]
10. Ten-year outcomes of high-dose intensity-modulated radiation therapy for nonmetastatic prostate cancer with unfavorable risk: early initiation of salvage therapy may replace long-term adjuvant androgen deprivation.
Aizawa R; Takayama K; Nakamura K; Inoue T; Yamasaki T; Kobayashi T; Akamatsu S; Ogawa O; Mizowaki T
Int J Clin Oncol; 2019 Oct; 24(10):1247-1255. PubMed ID: 31152322
[TBL] [Abstract][Full Text] [Related]
11. Survival Outcomes of Men with Lymph Node-positive Prostate Cancer After Radical Prostatectomy: A Comparative Analysis of Different Postoperative Management Strategies.
Touijer KA; Karnes RJ; Passoni N; Sjoberg DD; Assel M; Fossati N; Gandaglia G; Eastham JA; Scardino PT; Vickers A; Cozzarini C; Montorsi F; Briganti A
Eur Urol; 2018 Jun; 73(6):890-896. PubMed ID: 29042125
[TBL] [Abstract][Full Text] [Related]
12. Outcomes for Young Men With Localized Intermediate-Risk Prostate Cancer: An Analysis of the NCDB.
Chua S; Qureshi MM; Boyd G; Gignac GA; Hirsch AE
Clin Genitourin Cancer; 2020 Oct; 18(5):e531-e542. PubMed ID: 32220567
[TBL] [Abstract][Full Text] [Related]
13. Superior survival benefits of Radical Prostatectomy than External Beam Radiotherapy in aging 75 and older men with high-risk or very high-risk Prostate Cancer: a population-matched study.
Wang Y; Song P; Wang J; Shu M; Wang Q; Li Q
J Cancer; 2020; 11(18):5371-5378. PubMed ID: 32742483
[No Abstract] [Full Text] [Related]
14. Persistent Prostate-Specific Antigen After Radical Prostatectomy and Its Impact on Oncologic Outcomes.
Preisser F; Chun FKH; Pompe RS; Heinze A; Salomon G; Graefen M; Huland H; Tilki D
Eur Urol; 2019 Jul; 76(1):106-114. PubMed ID: 30772034
[TBL] [Abstract][Full Text] [Related]
15. Survival after radiotherapy vs. radical prostatectomy for unfavorable intermediate-risk prostate cancer.
Sebastian NT; McElroy JP; Martin DD; Sundi D; Diaz DA
Urol Oncol; 2019 Nov; 37(11):813.e11-813.e19. PubMed ID: 31109836
[TBL] [Abstract][Full Text] [Related]
16. Intensity-modulated radiotherapy versus radical prostatectomy in patients with localized prostate cancer: long-term follow-up.
Merino T; San Francisco IF; Rojas PA; Bettoli P; Zúñiga A; Besa P
BMC Cancer; 2013 Nov; 13():530. PubMed ID: 24209381
[TBL] [Abstract][Full Text] [Related]
17. The need for androgen deprivation therapy in patients with intermediate-risk prostate cancer treated with dose-escalated external beam radiation therapy.
Dong Y; Ruth KJ; Churilla TM; Viterbo R; Sobczak ML; Smaldone MC; Chen DY; Uzzo RG; Hallman MH; Horwitz EM
Can J Urol; 2017 Feb; 24(1):8656-8662. PubMed ID: 28263132
[TBL] [Abstract][Full Text] [Related]
18. Comparative effectiveness of treatments for high-risk prostate cancer patients.
Jayadevappa R; Lee DI; Chhatre S; Guzzo TJ; Malkowicz SB
Urol Oncol; 2019 Sep; 37(9):574.e11-574.e18. PubMed ID: 31285113
[TBL] [Abstract][Full Text] [Related]
19. Local Therapy Improves Overall Survival in Patients With Newly Diagnosed Metastatic Prostate Cancer.
Parikh RR; Byun J; Goyal S; Kim IY
Prostate; 2017 May; 77(6):559-572. PubMed ID: 28093791
[TBL] [Abstract][Full Text] [Related]
20. Cancer-Specific Mortality Among Korean Men with Localized or Locally Advanced Prostate Cancer Treated with Radical Prostatectomy Versus Radiotherapy: A Multi-Center Study Using Propensity Scoring and Competing Risk Regression Analyses.
Koo KC; Cho JS; Bang WJ; Lee SH; Cho SY; Kim SI; Kim SJ; Rha KH; Hong SJ; Chung BH
Cancer Res Treat; 2018 Jan; 50(1):129-137. PubMed ID: 28279064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]